Glanzmann's Research
Foundation (GRF) was established in 2001 after discovering
a researcher who is actively pursuing a cure for GT. The
idea was to promote awareness about Glanzmann's Thrombasthenia
and to aid in research efforts being made to correct this
disorder. GRF is recognized by the IRS as a non-profit,
501-C3 organization, governed by a board of directors.
The Board
of Directors:
Helen
Smith, Founder
Glanzmann's Research Foundation |
Barrett
Cochran
PCE - ER |
Benjamin
B. Barmore, Sr.
CPA
Partner , Baird & Company |
Bruce
Friedman, MD
Critical Care Director
Joseph M. Still Burn Center |
Kalyani
Friedman, MD
Anesthesiologist |
Michael
Brown, Owner
Chik Fil A; Augusta Exchange |
Paige
Cochran
Insurance Agent
Joesbury Insurance Agency |
Darren
Meadows
Attorney
Hull, Towill, Norman, Barrett & Salley |
Dr.
David Wilcox, a professor at the Medical College of
Wisconsin has been the benefactor of previous contributions
from the GRF due to the fact that he has had some amazing
success in his laboratory. He has corrected GT in human
cells in the lab environment. It is vital that his research
receive the funding required in order to take the success
he’s achieved in the lab and apply it to people in
the GT population. The money raised by the Glanzmann’s
Research Foundation goes directly towards the advancement
of the research being done to cure GT.
Dr.
Wilcox has shown us how donations from the GRF have been
applied to his previous research and demonstrated where
contributions from the GRF will continue be used in the
advancement of his research.
With
our continued support, Dr. Wilcox expects to be able to
cure GT within the next 10 to 15 years. Imagine being able
to participate in advancing medical science so far that
GT becomes a footnote in history alongside polio, scurvy,
small pox and all the other diseases and disorders we no
longer live in fear of.
Donations
& funding requests should be made in writing and mailed
to:
Glanzmann's Research
Foundation
3563 Granite Way
Martinez, GA 30907
USA
